MARKET

TNGX

TNGX

Tango Therapeutics Inc
NASDAQ
23.37
-0.63
-2.63%
After Hours: 23.11 -0.26 -1.11% 17:08 09/10 EDT
OPEN
23.16
PREV CLOSE
24.00
HIGH
24.30
LOW
23.16
VOLUME
3.44M
TURNOVER
--
52 WEEK HIGH
34.39
52 WEEK LOW
6.25
MARKET CAP
3.94B
P/E (TTM)
-27.6896
1D
5D
1M
3M
1Y
5Y
1D
Why Is Tango Therapeutics (TNGX) Down 6.2% Since Last Earnings Report?
NASDAQ · 6h ago
Caleres Posts Upbeat Q2 Earnings, Joins Opus Genetics, Flotek Industries And Other Big Stocks Moving Higher On Wednesday
Benzinga · 1d ago
Weekly Report: what happened at TNGX last week (0831-0904)?
Weekly Report · 3d ago
Most shorted stocks on Wall Street
Seeking Alpha · 09/02 14:28
Most and least shorted mid- to mega-cap healthcare stocks at the end of August
Seeking Alpha · 09/02 14:00
Weekly Report: what happened at TNGX last week (0824-0828)?
Weekly Report · 08/31 09:30
Weekly Report: what happened at TNGX last week (0817-0821)?
Weekly Report · 08/24 09:31
Tango Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 08/18 11:36
More
About TNGX
Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering precision medicine for the treatment of cancer. The Company's novel small molecules are designed to be selectively active in cancer cells with specific genetic alterations, killing those cancer cells while sparing normal cells. The Company is focused on clinical development of two methylthioadenosine phosphorylase (MTAP)-deleted selective PRMT5 inhibitors: vopimetostat (TNG462) for non-CNS cancers, both as a monotherapy and in combination with RAS inhibitors, and TNG456, brain-penetrant protein arginine methyltransferase 5 (PRMT5) inhibitor, for CNS cancers, including glioblastoma (GBM). Its TNG260 is a first-in-class Co-repressor of the Repressor Element-1 Silencing Transcription (CoREST) inhibitor, which in preclinical studies reversed the immune evasion effect of STK11 loss-of-function mutations.

Webull offers Tango Therapeutics Inc stock information, including NASDAQ: TNGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNGX stock methods without spending real money on the virtual paper trading platform.